Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men, according to a study published ...
The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...
Sanofi and Regeneron's fast-growing immunology drug Dupixent is on course for a third indication in Europe after being recommended for approval as a treatment for people with nasal polyps. Dupixent ...
The Healthy on MSN
Chronic Nasal Congestion: 7 Reasons You Always Feel Stuffed Up
“The lining of our nose is complex, and the increased blood flow that goes through the lining of the nose can lead to ...
MyChesCo on MSN
AstraZeneca and Amgen Secure FDA Approval for TEZSPIRE to Treat Chronic Rhinosinusitis with Nasal Polyps
AstraZeneca and Amgen have received U.S. Food and Drug Administration (FDA) approval for TEZSPIRE® (tezepelumab-ekko) as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results